𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PDLIM4 Repression by Hypermethylation as a Potential Biomarker for Prostate Cancer

✍ Scribed by Vanaja, D. K.

Book ID
118736176
Publisher
American Association for Cancer Research
Year
2006
Tongue
English
Weight
502 KB
Volume
12
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

GSTP1 CpG island hypermethylation as a m
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
✍ Masashi Nakayama; Mark L. Gonzalgo; Srinivasan Yegnasubramanian; Xiaohui Lin; An πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 295 KB

## Abstract Somatic hypermethylation of CpG island sequences at __GSTP1__, the gene encoding the π‐class glutathione S‐transferase, appears to be characteristic of human prostatic carcinogenesis. To consider the potential utility of this epigenetic alteration as a biomarker for prostate cancer, we

Transforming growth factor Ξ²1 as a bioma
Transforming growth factor Ξ²1 as a biomarker for prostate cancer
✍ Timothy C. Thompson; Luan D. Truong; Terry L. Timme; Dov Kadmon; Bryan K. McCune πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 851 KB

Using the mouse prostate reconstitution (MPR) model system, under conditions where the ras and myc oncogenes are introduced via a recombinant retrovirus into both the mesenchymal and epithelial compartments of the urogenital sinus, poorly differentiated prostate cancer is produced with high frequenc